Evidence map›Paper›PMID 40301255›Full record

ReviewAdvances in experimental medicine and biology2025

Effect of Endocrine Disruptors on Testicular Function.

Latchoumycandane Calivarathan, Premendu Prakash Mathur

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Latchoumycandane CalivarathanMolecular Pharmacology and Toxicology Laboratory, Department of Biotechnology, School of Integrative Biology, Central University of Tamil Nadu, Thiruvarur, India.
Premendu Prakash MathurBirla Global University, Bhubaneswar, Odisha, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several classes of exogenous chemicals interfere with the endocrine system and disrupt the normal functioning of hormones, leading to a wide range of adverse health effects. The male reproductive system is particularly vulnerable to endocrine disruption, as it involves complex interactions between endocrine, paracrine, and autocrine signals that regulate spermatogenesis and steroidogenesis within the testes. Exposure to endocrine disruptors (EDs) has been associated with reduced semen quality, including decreased sperm concentration, motility, and morphology. Some endocrine disruptors have also been linked to alterations in testosterone levels, which impact overall male reproductive health. Bisphenol A, phthalates, dioxins, polychlorinated biphenyls, organophosphate pesticides, and phytoestrogens are well-known endocrine disruptors that interfere with male reproductive functions. Furthermore, these substances have been associated with an increased risk of reproductive disorders such as cryptorchidism, hypospadias, and testicular cancer. Due to the presence of endocrine-disrupting chemicals in numerous consumer goods and personal care products, people encounter these harmful substances through ingestion, absorption, inhalation, and skin contact. However, the duration of exposure to a particular endocrine disruptor or exposure during a particular stage of development is the determining factor for testicular function. This chapter provides a comprehensive overview of the effects of endocrine disruptors on testicular function, from molecular mechanisms to clinical outcomes.

Indexed as

Endocrine DisruptorsTestisAnimalsHumansInfertility, MaleMaleSpermatogenesisTesticular NeoplasmsEndocrine DisruptorsEndocrine disruptorsMale reproductionPhthalatesSpermatogenesisTestis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.